Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Researchers have successfully developed nerve grafts, currently being trialed as a treatment for Parkinson’s disease, that ...

Stem cell therapies are a safe and effective way of treating Parkinson's disease, according to results of two independent ...

In a groundbreaking Phase I/II trial conducted at Kyoto University Hospital, researchers have demonstrated the potential of iPS-cell-derived dopaminergic progenitors in treating Parkinson’s disease.

The researchers believe that the stem-cell treatment indeed holds the key to stopping Parkinson's Disease in its tracks, a ...

A new Drosophila collection of Parkinsonism models reveals early synaptic cholinergic projection neuron dysfunction, linking synaptic failure to later dopaminergic decline, highlighting a role for ...

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with ...

Parkinson’s disease (PD) is a neurodegenerative disease of the central nervous system characterized by the loss of dopaminergic neurons in the substantia nigra and the abnormal aggregation of ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...